Ivacaftor improves appearance of sinus disease on computerised tomography in cystic fibrosis patients with G551D mutation

Clinical Otolaryngology

Volumn 40, Issue 1, 2015, Pages 16-21

  Sheikh, S I ^a,b   Long, F R ^a,c   Mccoy, K S ^a,b   Johnson, T ^b   Ryan Wenger, N A ^a,b   Hayes, D ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; IVACAFTOR; AMINOPHENOL DERIVATIVE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MALE; MUTATION; OBSERVATIONAL STUDY; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; SWEAT; YOUNG ADULT; COHORT ANALYSIS; COMPLICATION; GENETICS; GENOTYPE; PARANASAL SINUS DISEASES; RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMINOPHENOLS; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; PARANASAL SINUS DISEASES; QUINOLONES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84921381430     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/coa.12310     Document Type: Article

References (18)

1. Knowles M., Gatzy J. & Boucher R. (1983) Relative ion permeability of normal and cystic fibrosis nasal epithelium. J. Clin. Invest. 71, 1410-1417
2. Welsh M.J. (1986) An apical-membrane chloride channel in human tracheal epithelium. Science 232, 1648-1650
3. Rowe S.M., Miller S. & Sorscher E.J. (2005) Cystic fi brosis. N. Engl. J. Med. 352, 1992-2001
4. Cystic Fibrosis Foundation Patient Registry (2010) 2009 Annual Data Report to the Center Directors. Cystic Fibrosis Foundation Patient Registry, Bethesda, MD
5. Denning G.M., Anderson M.P., Amara J.F. et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764
6. Kartner N., Augustinas O., Jensen T.J. et al. (1992) Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat. Genet. 1, 321-327
7. Van Goor F., Straley K.S., Cao D. et al. (2006) Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L1117-L1130
8. Bobadilla J.L., Macek M. Jr, Fine J.P. et al. (2002) Cystic f brosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum. Mutat. 19, 575-606
9. Cystic Fibrosis Foundation (2008) Patient Registry: 2007 Annual Data Report to the Center Directors. Cystic Fibrosis Foundation, Bethesda, MD.
10. Van Goor F., Hadida S., Grootenhuis P.D. et al. (2009) Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl Acad. Sci. USA 106, 18825-18830
11. Accurso F.J., Rowe S.M., Clancy J.P. et al. (2010) Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N. Engl. J. Med. 363, 1991-2003
12. Ramsey B.W., Davies J., McElvaney N.G. et al. (2011) VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 365, 1663-1672
13. Center for Drug Evaluation and Research. Kalydeco (ivacaftor). Labeling. US Food and Drug Administration, Silver Spring, MD. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203188Orig1s000Lbl.pdf [accessed on August 29, 2012].
14. American Thoracic Society (1995) Standardization of spirometry, 1994 update. Am. J. Respir. Crit. Care Med. 152, 1107-1136
15. Rose J.B., Ellis L., John B. et al. (2009) Does the Macroduct collection system reliably define sweat chloride concentration in subjects with intermediate results? Clin. Biochem. 42, 1260-1264
16. Rasmussen J., Aanæs K., Norling R. et al. (2012) CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. J. Cyst. Fibros. 11, 93-99
17. Eggesbø H.B., Søvik S., Dølvik S. et al. (2002) CT characterization of inflammatory paranasal sinus disease in cystic fibrosis. Acta Radiol. 43, 21-28
18. McMurphy A.B., Morriss C., Roberts D.B. et al. (2007) The usefulness of computed tomography scans in cystic fibrosis patients with chronic sinusitis. Am. J. Rhinol. 21, 706-710